Newbridge Financial Services Group, Inc. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
Newbridge Financial Services Group, Inc. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$0
-100.0%
0
-100.0%
0.00%
Q2 2023$856
+9.3%
210.0%0.00%
Q1 2023$783
+6.8%
210.0%0.00%
Q4 2022$733
-26.7%
210.0%0.00%
-100.0%
Q3 2022$1,000
-66.7%
21
-63.2%
0.00%
-50.0%
Q2 2022$3,000
-94.6%
57
-92.7%
0.00%
-92.9%
Q1 2022$56,000
-8.2%
776
+49.2%
0.03%
-3.4%
Q4 2021$61,000
+1120.0%
520
+1344.4%
0.03%
+866.7%
Q3 2021$5,000
-50.0%
36
-40.0%
0.00%
-50.0%
Q2 2021$10,000
+100.0%
600.0%0.01%
+50.0%
Q1 2021$5,000600.00%
Q3 2020$000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders